Mitochondrial Calcium Overload Drives mtDNA-cGAS-STING Activation via VDAC1 and MCU Upregulation in Periodontitis

Xinyi Cheng1, Yu Cai1, Yiran Geng1

  • 1Department of Periodontology, Peking University School and Hospital of Stomatology, National Center of Stomatology, National Clinical Research Center for Oral Diseases, National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing 100081, China.

Insights

Mitochondrial calcium overload contributes to periodontitis by damaging mitochondria and activating immune responses. Targeting calcium channels VDAC1 and MCU may offer new treatments for this gum disease.

Area of Science:

  • Oral biology and immunology
  • Mitochondrial biology
  • Inflammatory disease mechanisms

Background:

  • Periodontitis pathogenesis involves chronic inflammation and mitochondrial dysfunction.
  • Calcium (Ca2+) homeostasis is critical for mitochondrial function.
  • Mechanisms linking mitochondrial Ca2+ dysregulation to periodontitis are unclear.

Purpose of the Study:

  • Investigate the role of mitochondrial calcium (mtCa2+) dysregulation in periodontitis.
  • Examine the relationship between mtCa2+ overload, mitochondrial damage, and immune activation.
  • Identify potential therapeutic targets for periodontitis.

Main Methods:

  • Analysis of gingival tissues from periodontitis patients and controls.
  • In vitro studies using gingival fibroblasts stimulated with Porphyromonas gingivalis lipopolysaccharide.
  • Techniques included electron microscopy, confocal imaging, flow cytometry, qPCR, and western blotting.

Main Results:

  • mtCa2+ overload and disrupted whole-cell Ca2+ homeostasis were observed in periodontitis.
  • Mitochondrial damage, mitochondrial DNA (mtDNA) leakage, and cGAS-STING pathway activation occurred.
  • VDAC1 and MCU expression correlated with disease severity (probing depth).

Conclusions:

  • mtCa2+ overload is linked to mtDNA leakage and innate immune activation in periodontitis.
  • VDAC1 and MCU are upregulated in periodontitis and contribute to pathogenesis.
  • Inhibiting VDAC1 or MCU reduced inflammation and may be therapeutic strategies for periodontitis.